NO870475L - Fremgangsmaate for fremstilling av vaksiner mot melanoma. - Google Patents

Fremgangsmaate for fremstilling av vaksiner mot melanoma.

Info

Publication number
NO870475L
NO870475L NO87870475A NO870475A NO870475L NO 870475 L NO870475 L NO 870475L NO 87870475 A NO87870475 A NO 87870475A NO 870475 A NO870475 A NO 870475A NO 870475 L NO870475 L NO 870475L
Authority
NO
Norway
Prior art keywords
melanoma
procedure
preparing vaccines
vaccines
preparing
Prior art date
Application number
NO87870475A
Other languages
English (en)
Other versions
NO178931C (no
NO178931B (no
NO870475D0 (no
Inventor
Joseph P Brown
Gregory D Plowman
Karl E Hellstrom
Anthony F Purchio
Sridhar Pennathur
Charles D Estin
Timothy M Rose
Ingegerd Hellstrom
Shiu-Lok Hu
Original Assignee
Oncogen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26676698&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO870475(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/007,230 external-priority patent/US5262177A/en
Application filed by Oncogen filed Critical Oncogen
Publication of NO870475D0 publication Critical patent/NO870475D0/no
Publication of NO870475L publication Critical patent/NO870475L/no
Priority to NO921496A priority Critical patent/NO921496D0/no
Publication of NO178931B publication Critical patent/NO178931B/no
Publication of NO178931C publication Critical patent/NO178931C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hospice & Palliative Care (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO870475A 1986-02-07 1987-02-06 Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus NO178931C (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO921496A NO921496D0 (no) 1986-02-07 1992-04-15 Fremgangsmaate for fremstilling av et peptid eller proteinbeslektet med det melanomaforbundne p97-antigen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82731386A 1986-02-07 1986-02-07
US07/007,230 US5262177A (en) 1986-02-07 1987-01-27 Recombinant viruses encoding the human melanoma-associated antigen

Publications (4)

Publication Number Publication Date
NO870475D0 NO870475D0 (no) 1987-02-06
NO870475L true NO870475L (no) 1987-08-10
NO178931B NO178931B (no) 1996-03-25
NO178931C NO178931C (no) 1996-07-03

Family

ID=26676698

Family Applications (1)

Application Number Title Priority Date Filing Date
NO870475A NO178931C (no) 1986-02-07 1987-02-06 Fremgangsmåte for fremstilling av et hovedsakelig rent, terapeutisk aktivt antigent protein, og ekspresjonssystem bestående av et rekombinant virus

Country Status (18)

Country Link
JP (3) JP2664673B2 (no)
BE (1) BE1000175A3 (no)
CH (1) CH675424A5 (no)
DE (1) DE3703702C2 (no)
DK (1) DK63287A (no)
ES (2) ES2012815A6 (no)
FI (1) FI94836C (no)
GR (1) GR870195B (no)
HU (1) HU209144B (no)
IE (1) IE59597B1 (no)
IT (1) IT1222359B (no)
MX (1) MX9203574A (no)
NL (1) NL8700285A (no)
NO (1) NO178931C (no)
NZ (1) NZ219192A (no)
OA (1) OA08478A (no)
PT (1) PT84255B (no)
SE (2) SE506024C2 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19821925A1 (de) * 1998-05-15 1999-11-18 Roehnisch Tim Verfahren zur Herstellung einer Zusammensetzung zur Induktion einer tumorspezifischen Immunantwort, sowie Verwendung der Zusammensetzung zur Behandlung von Neoplasien
JP4414023B2 (ja) * 1999-08-05 2010-02-10 オリエンタル酵母工業株式会社 関節炎関連メラノトランスフェリンの測定方法および試薬
JP4708027B2 (ja) * 2002-10-01 2011-06-22 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 抗癌組成物および抗感染疾患組成物ならびにこれらを使用する方法
US8207314B2 (en) * 2003-05-16 2012-06-26 Sanofi Pasteur Limited Tumor antigens for prevention and/or treatment of cancer

Also Published As

Publication number Publication date
FI870501A (fi) 1987-08-08
IE59597B1 (en) 1994-03-09
SE8700466D0 (sv) 1987-02-06
HUT43107A (en) 1987-09-28
HU209144B (en) 1994-03-28
DK63287A (da) 1987-08-08
FI94836B (fi) 1995-07-31
IE870319L (en) 1987-08-07
JP2664673B2 (ja) 1997-10-15
IT8719291A0 (it) 1987-02-06
NZ219192A (en) 1991-10-25
DK63287D0 (da) 1987-02-06
GR870195B (en) 1987-06-10
FI94836C (fi) 1995-11-10
NO178931C (no) 1996-07-03
JPH09135692A (ja) 1997-05-27
NL8700285A (nl) 1987-09-01
PT84255B (pt) 1989-11-30
SE506024C2 (sv) 1997-11-03
BE1000175A3 (fr) 1988-07-12
DE3703702C2 (de) 1997-07-10
JPH08280390A (ja) 1996-10-29
CH675424A5 (en) 1990-09-28
OA08478A (fr) 1988-07-29
PT84255A (en) 1987-03-01
IT1222359B (it) 1990-09-05
NO178931B (no) 1996-03-25
FI870501A0 (fi) 1987-02-06
NO870475D0 (no) 1987-02-06
ES2017258A6 (es) 1991-01-16
ES2012815A6 (es) 1990-04-16
JPS62294698A (ja) 1987-12-22
DE3703702A1 (de) 1988-02-18
SE8700466L (sv) 1987-08-08
SE9202934D0 (sv) 1992-10-07
MX9203574A (es) 1992-07-01

Similar Documents

Publication Publication Date Title
NO872682L (no) FremgangsmŸte for fremstilling av imidazopyridiner.
NO874347D0 (no) Fremgangsmaate for fremstilling av insulin.
FR2601370B1 (fr) Vaccin contre le melanome.
IT8721307A0 (it) Cappuccino. dispositivo per preparare
NO903656D0 (no) Fremgangsmaate for fremstilling av 17beta-acyl-4-aza-5alfa-androst-1-en-3-oner.
DE3785404D1 (de) Impfstoffe.
NO873472L (no) Fremgangsmaate for fremstilling av soetsaker.
NO872831L (no) FremgangsmŸte for fremstilling av nitrofuranderivater.
NO861114L (no) Fremgangsmaate for fremstilling av polyisocyanat-polyisocyanurater.
NO901832D0 (no) Fremgangsmaate for fremstilling av polyketon.
DE3786301D1 (de) Kombinierter impfstoff.
NO863756D0 (no) Metode for fremstilling av celleplast.
NO873213D0 (no) Fremgangsmaate for fremstilling av transdermale preparater.
IT1237508B (it) Procedimento per preparare n-fosfonometilglicina.
NO872587D0 (no) Forbedret limpreparat og fremgangsmaate for fremstilling av dette.
NO885435D0 (no) Fremgangsmaate for fremstilling av benzotiazepinderivater.
NO871759D0 (no) Fremgangsmaate for fremstilling av sucralfat-preparater.
NO870475D0 (no) Fremgangsmaate for fremstilling av vaksiner mot melanoma.
NO883339D0 (no) Fremgangsmaate for fremstilling av benzimidazol-2-yl-pyridiniumforbindelser.
NO870828L (no) FremgangsmŸte for fremstilling av biskarbamater.
NO874958D0 (no) Fremgangsmaate for fremstilling av 1-aryloksy-3-amino-2-propanoler.
DE3782960D1 (de) Impfstoffe.
FI872802A (fi) Vaccin mot protozonparasiter.
NO161779C (no) Fremgangsmaate for fremstilling av et antiforkjoelsespreparat.
NO903196D0 (no) Fremgangsmaate for fremstilling av 2-diazo-3-trisubstituerte silyloksy-3-butenoater.